Senseonics (NYSE:SENS) announced today that the FDA approved its next-generation continuous glucose monitor system, which lasts up to half a year. Germantown, Maryland–based Senseonics designed the Eversense E3, which includes proprietary sacrificial boronic acid (SBA) technology, to extend longevity to six months (180 days). Senseonics previously offered the system with a 90-day wear time. Data […]
Ascensia Diabetes Care
Ascensia inks CGM distro, development deal with Poctech
Ascensia Diabetes Care said this week that inked a deal to co-develop and distribute continuous glucose monitoring systems with device developer Poctech. According to the terms of the deal, Ascensia will become the exclusive distributor for Poctech’s existing CGM product in 13 selected markets. Ascensia said it plans to start distributing the device in the […]
Medtronic wins CE Mark for MiniMed 670G hybrid closed-loop insulin system
Medtronic (NYSE:MDT) said today that it won CE Mark approval in the European Union for its MiniMed 670G hybrid closed-loop insulin management system for Type I diabetes patients age 7 and older. Fridley, Minn.-based Medtronic said it has clinical programs under way to back expanded indications for the device, which is designed to continuously monitor regulate […]
Ascensia Diabetes Care launches upgraded blood glucose monitor app
Ascensia Diabetes Care announced today the launch of an upgraded version of its Contour Diabetes app in 24 countries. The latest version of the company’s app includes algorithms to analyze blood glucose data collected from the Contour Next One meter and gives personalized feedback to users. The upgraded app was recently launched in Austria, Belgium, Canada, […]
Ascensia looks to expand access to blood glucose monitoring tech for UnitedHealthcare enrollees
Ascensia Diabetes Care inked a new relationship with UnitedHealthcare (NYSE:UNH), the company touted today, which is designed to improve access to Ascensia’s Contour Next blood glucose meters and test strips for UnitedHealthcare members. Now, people enrolled in UnitedHealthcare’s employer or commercial plans can get a meter or test trip through their pharmacy benefit at a Tier 2 […]
Ascensia inks global distro sale with Insulet for blood glucose monitor
Ascensia Diabetes Care has expanded its partnership with Insulet (NSDQ:PODD) to include a global commercial deal. The two companies inked a world-wide development agreement in June last year to connect Ascensia’s Contour Next One blood glucose monitor with Insulet’s next-gen Omnipod system, Omnipod Dash. According to the terms of the non-exclusive commercial deal, Insulet plans to distribute […]
Ascensia Diabetes Care highlights women helping to advance diabetes care
In support of World Diabetes Day earlier this month, Ascensia Diabetes Care published 30 portraits of women who are working to advance diabetes care. The company’s CEO, Michael Kloss, said he was inspired by the theme of this year’s annual event, Women and Diabetes, and turned within the company for nominations of inspiring women. “We initially […]
Ascensia Diabetes Care partners for mobile insulin management app
Ascensia Diabetes Care and Quattro Folia said today that the companies are partnering to combine Ascensia’s Contour Next One blood glucose monitoring system and Quattro Folia’s Balansio mobile insulin management app. According to the deal, the Contour Next One meter will connect via Bluetooth to the Balansio mobile app and deliver blood glucose readings to […]
Ascensia Diabetes Care inks integration deal with Insulet
Ascensia Diabetes Care said today it inked a strategic alliance with Insulet (NSDQ:PODD) to integrate connectivity between Insulet’s next-gen Omnipod system with Ascensia’s Contour Next One blood glucose monitoring system. Through the deal, Parsippany, N.J.-based Ascensia’s Contour Next will be designed to pair via Bluetooth with the Omnipod Dash personal diabetes manager to automatically communicate blood glucose […]
FDA clears Ascensia’s Contour Next One blood glucose monitor
Ascensia Diabetes Care said today that it won FDA 510(k) clearance for its Contour Next One blood glucose monitoring system. The connected system features a blood glucose meter that links to mobile devices using Bluetooth through the Contour Diabetes app. The app can collect, store and analyze the patient’s blood glucose measurements for patterns and […]
